期刊文献+

PTEN与CyclinD1蛋白在卵巢上皮性肿瘤的表达及意义 被引量:2

Expressions and significances of PTEN and CyclinD1 protein in epithelial tumor of ovary
原文传递
导出
摘要 目的:探讨卵巢上皮性肿瘤中PTEN与CyclinD1的表达及临床意义。方法:应用免疫组织化学方法检测20例正常卵巢组织、15例卵巢良性肿瘤、40例上皮性卵巢癌中PTEN和CyclinD1的表达。结果:PTEN在正常卵巢组织、卵巢良性肿瘤、上皮性卵巢癌中的表达率呈逐渐下降的趋势(P<0.05);PTEN的表达与分化、FIGO分期有关;正常卵巢组织和良性肿瘤中CyclinD1蛋白呈低表达水平,但在上皮性卵巢癌中的表达率和强度明显增加,CyclinD1的表达与分化、FIGO分期、淋巴结转移有关;二者表达成负相关(P<0.01)。结论:PTEN的表达缺失与CyclinD1蛋白表达增强在上皮性卵巢癌的发生、发展过程中起到重要作用。 Objective: To explore the expressions and clinical significances of PTEN and CyclinD1 in epithelial tumor of ovary. Methods: Immunohistochemical method was used to detect the expression levels of PTEN and CyclinD1 protein in 20 cases with normal ovarian tissues, 15 cases with benign ovarian tumors and 40 cases with epithelial ovarian cancer. Results: The expression rates of PTEN in normal ovarian tissues, benign ovarian tumors and epithelial ovarian cancer showed a gradual decreasing trend ( P 〈 0.05 ) . PTEN expression was related to differentiation and FIGO stages ; the expression levels of CyclinD1 protein in normal ovarian tissues and benign ovarian tumors were low, but the expression rate and intensity of CyelinD1 protein in epithelial ovarian cancer increased significantly, CyclinD1 protein expression was related to differentiation, FIGO stages and lymph node metastasis; there was a negative correlation between PTEN expression and CyclinD1 protein expression (P 〈 0. 01 ) . Conclusion: The deletion of PTEN expression and high expression of CyclinD1 protein play important roles in the occurrence and development of epithelial ovarian cancer.
出处 《中国妇幼保健》 CAS 北大核心 2011年第17期2672-2674,共3页 Maternal and Child Health Care of China
关键词 PTEN 细胞周期素D1 卵巢肿瘤 免疫组织化学 PTEN CyelinD1 Ovarian tumor Immunohistochemistry
  • 相关文献

参考文献3

二级参考文献26

  • 1任占平,郑绍光,陈尉麟.应用SP免疫组化染色法的体会[J].诊断病理学杂志,1994,1(3):176-176. 被引量:69
  • 2[1]Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-62.
  • 3[2]Gu J, Tamura M, Yamada KM. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 1998; 143:1375-83.
  • 4[3]Tamura M, Gu J, Takino T, et al. Tumor suppressor PTEN inhibition of cell invasion, migration and growth:differential involvement of focal adhesion kinase and p130Cas. Cancer Res 1999;59:442-9.
  • 5[4]Tamura M, Gu J, Tran H, et al. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 1999;91:1820-8.
  • 6[5]Cantley LC, Neel BG. New insight into tumor suppression:PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999;96:4240-5.
  • 7[6]Koul D, Parthasarathy R, Shen R, et al. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 2001;20:6669-78.
  • 8[7]Huang J, Kontos CD. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 2002;277:10760-6.
  • 9[8]Birck A, Ahrenkiel V, Zeuthern J, et al. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. J Invest Dermatol 2000;114:277-80.
  • 10[9]Tashiro H, Blazes MS, Wu R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997;57:3935 -40.

共引文献33

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部